Use of insulin glargine during pregnancy: a case-control pilot study
- 1 April 2007
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 114 (4), 453-457
- https://doi.org/10.1111/j.1471-0528.2006.01216.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?Diabetes/Metabolism Research and Reviews, 2005
- Evaluation of the Reproductive Toxicity and Embryotoxicity of Insulin Glargine (LANTUS) in Rats and RabbitsInternational Journal of Toxicology, 2002
- Insulins today and beyondThe Lancet, 2001
- Treatment satisfaction and psychological well‐being with insulin glargine compared with NPH in patients with Type 1 diabetesDiabetic Medicine, 2001
- Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.Diabetes Care, 2000
- Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.Diabetes, 2000
- Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.Diabetes Care, 2000
- Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor.Diabetologia, 1997
- Prevention of Perinatal Morbidity by Tight Metabolic Control in Gestational Diabetes MellitusDiabetes Care, 1988
- New birthweight and head circumference centiles for gestational ages 24 to 42 weeksEarly Human Development, 1987